Valeant Adds Robert Hale To Board
This article was originally published in Scrip
Executive Summary
Valeant Pharmaceuticals International, Inc. has appointed D. Robert Hale to its board of directors and in parallel announced the resignation of director Jeffrey W. Ubben.